Skip to main content

Nifty bounces, but yesterday's damage lingers

One ugly session doesn't erase itself with a 0.3% recovery — the internals still need watching.

Thursday, 9 July 20262 min readStage2Stocks Market Desk

Nifty 50
23,963
+0.3% on the day
Market
Neutral — Building
27 sessions in this state
Breadth
41%
above 200-DMA · narrow
Adv / Dec
1,702 / 510
advancers ahead
52w highs / lows
171 / 75
net +96
Stage-2 share
35%
cohort widening

Today's 0.3% Nifty bounce is a one-day reflex after Tuesday's 2.1% drop, not a cleared bill of health. The short-term breadth gauge collapsed from 62 to 35 over the past week before today's partial recovery to 43 — that kind of damage takes more than a single green close to repair. This is a dip inside a structurally recovering tape, but the short-term internals are still healing, and the index remains below its 200-day average and 9% off its 52-week high.

Trajectory: one-day bounce inside a bruised tape

The continuity series tells the story plainly. The slow structural gauge — the share of stocks above their 200-day average — slid from 44 to 39 during Tuesday's selloff and has only partially recovered to 41 today; that is a meaningful structural dent, not a blip. The fast short-term gauge fell harder, from 62 a week ago to 35 on Tuesday, and today's read of 43 is a bounce, not a reset. Net new highs went negative on Tuesday — the first time in this series — and today's recovery to 96 is welcome but still well below the 158 printed a week ago. Advancers led decliners 1,702 to 510 today, which looks strong in isolation, but the prior three sessions ran 929-1,288, 727-1,477 and 334-1,884 — the market spent most of this week distributing, and one good day does not reverse that.

Leadership: Real Estate and Health Care carry the day, but the cohort is still narrow

Real Estate led all sectors at +3.3% today and is up 16% over the past month — it has been the most consistent performer in this recovery. Health Care added 1.4% and is where the Stage-2 cohort is expanding fastest over the past 20 days, with IND Swift Laboratories clearing the screen at the top of the setup rankings. Consumer Discretionary is the other sector where the advancing cohort is widening quickly, and Tirupati Forge appears on both the leading and pullback screens — though with volume below average, the setup lacks the conviction the tape needs right now. Information Technology remains a three-month laggard at -2.5% and is not where momentum is sitting.

Leading Stage-2 setups
StockSectorSetup% 1D
IND Swift Laboratories LtdHealth Care9.6+4.5%
Tirupati Forge LtdConsumer Discretionary9.4+1.6%
S.P.Apparels LtdConsumer Discretionary9.4+1.5%
Lokesh Machines LtdIndustrials9.3-2.0%
Aurum Proptech LtdInformation Technology9.0+1.3%
Beta Drugs LtdHealth Care9.0+9.6%
Pearl Global Industries LtdConsumer Discretionary9.0+1.4%
Bharat Seats LtdConsumer Discretionary8.9+6.7%
Sector performance — cap-weighted, ranked by today’s move
Sector1D1M3MRSStage 2
Real Estate+3.3%+16.1%+29.7%5122%
Communication Services+2.1%+7.7%+17.8%6218%
Health Care+1.4%+6.2%+21.8%7449%
Financials+1.1%+5.4%+8.7%6135%
Industrials+1.0%+2.8%+24.5%6839%
Consumer Staples+0.9%+2.5%+8.7%5733%
Materials+0.8%-0.5%+9.3%6739%
Consumer Discretionary+0.8%+5.6%+12.7%6634%
Information Technology+0.3%-2.1%-2.5%3427%
Energy+0.2%+1.3%+0.8%5339%
Utilities+0.0%-2.1%+20.7%6230%
Share of NSE stocks in Stage 2Jan 2026 – Jul 2026 · weekly
0%10%20%30%40%50%60%70%Jul 26Nifty 50Stocks in Stage 2Latest: 35%
The share of NSE stocks in Stage 2 over the six months to this wrap, with the Nifty's shape above it — the market underneath the day's numbers. Source: Stage2Stocks classification of every NSE stock with enough history, each week.
Try it on Stage2StocksHow to read this chart Lesson 3 of the course: why the Nifty isn't the market, and what the share of stocks in Stage 2 tells you.

Work the same data live: open the full stock screener, watch the live market dashboard, or check the market-timing read. New to the method? Start with the four stages.

Stage2Stocks is an educational stage-analysis screener. These wraps describe what the screen shows across NSE cash equities — they are not investment advice, recommendations, or buy/sell calls. Always do your own research.

All market wraps →